DE:7AL0 Stock Latest News
Company AnnouncementsAlligator Bioscience Appoints Nomination Committee for 2027 AGM2h ago
Company AnnouncementsAlligator Bioscience Sells Mitazalimab Rights to Biossil in Strategic Refocus on HLX223d ago
Company AnnouncementsAlligator Bioscience Boosts Share Count After Rights Issue4d ago
Company AnnouncementsAlligator Bioscience Plans 1-for-1,000 Reverse Share Split and Warrant Term Adjustments6d ago
Company AnnouncementsAlligator Bioscience Calls Extraordinary Meeting to Restructure Share Capital and Board6d ago
Company AnnouncementsAlligator Bioscience Refocuses Strategy on HLX22 and Bolsters Finances1w agoCompany AnnouncementsAlligator Bioscience to Present Q3 HER2-Focused Interim Report on 22 October2w ago
Company AnnouncementsAlligator Bioscience Names CFO Johan Giléus as CEO Amid Strategic Refocus on HLX221M ago
Company AnnouncementsAlligator Bioscience Restructures Fenja Loan With Directed Warrant Issue1M ago- Company AnnouncementsAlligator Bioscience’s Rights Issue Heavily Reliant on Guarantees, Triggers Major Dilution1M ago
- Company AnnouncementsAlligator Bioscience’s Rights Issue Undersubscribed, Underwriters Step In1M ago
Company AnnouncementsAlligator Bioscience Launches SEK 125.6 Million Rights Issue to Refocus Oncology Pipeline2M ago
Company AnnouncementsAlligator Bioscience Restructures Capital and Launches Major Rights Issue2M agoCompany AnnouncementsAlligator Bioscience exits mitazalimab development to refocus on HLX22 royalties and recapitalisation2M ago
Company AnnouncementsAlligator Bioscience Schedules August Earnings Call Amid Strategic Refocus2M ago
- Company AnnouncementsAlligator Bioscience Calls Extraordinary Meeting to Restructure Capital and Approve Rights Issue3M ago
- Company AnnouncementsAlligator Bioscience Shifts Focus to HLX22 and Launches SEK 125.6 Million Rights Issue3M ago
- Company AnnouncementsAlligator Bioscience Backs Intratumoral Mitazalimab Study in Early Breast Cancer4M ago
- Company AnnouncementsAlligator Bioscience Sees Revenue Upside as HLX22 Global Phase 3 Reaches Key Milestone4M ago
Company AnnouncementsAlligator Bioscience Sees Long-Term Revenue Potential in Henlius’ HLX22 Progress5M ago
Company AnnouncementsAlligator Bioscience AGM Backs Loss Carryforward and Expands Capital-Raising Mandate6M ago
Company AnnouncementsAlligator Bioscience Advances Oncology Pipeline and Bolsters Capital Base in Q1 20266M ago